Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer.
From: Department of Molecular Oncology, Genentech, Inc., South San Francisco, California 94114, USA.
Cancer research
- Publish Date: Jan 2006
- ISSN: 0008-5472
- Volume: 66
- Issue: 1
- Pages: 283-9
- Medium: Print
- Language: English
- Citation (JAMA): Kong-Beltran Monica, Seshagiri Somasekar, Zha Jiping, et al. Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer.. Cancer Res. Jan 2006;66:283-9
Abstract
Activating mutations in receptor tyrosine kinases play a critical role in oncogenesis. Despite evidence that Met kinase is deregulated in human cancer, the role of activating mutations in cancers other than renal papillary carcinoma has not been well defined. Here we report the identification of somatic intronic mutations of Met kinase that lead to an alternatively spliced transcript in lung cancer, which encodes a deletion of the juxtamembrane domain resulting in the loss of Cbl E3-ligase binding. The mutant receptor exhibits decreased ubiquitination and delayed down-regulation correlating with elevated, distinct Met expression in primary tumors harboring the deleted receptor. As a consequence, phospho-Met and downstream mitogen-activated protein kinase activation is sustained on ligand stimulation. Cells expressing the Met deletion reveal enhanced ligand-mediated proliferation and significant in vivo tumor growth. A hepatocyte growth factor competitive Met antagonist inhibits receptor activation and proliferation in tumor cells harboring the Met deletion, suggesting the important role played by ligand-dependent Met activation and the potential for anticancer therapy. These results support a critical role for Met in lung cancer and somatic mutation-driven splicing of an oncogene that leads to a different mechanism for tyrosine kinase activation through altered receptor down-regulation in human cancer.
Mesh Headings (Keywords): Alternative Splicing, Animals, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Colonic Neoplasms, Down-Regulation, Enzyme Activation, Exons, Female, Gene Deletion, Humans, Introns, Lung Neoplasms, Mice, Mice, Nude, Mitogen-Activated Protein Kinases, Mutation, Phosphorylation, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-cbl, Receptors, Growth Factor, Signal Transduction, Ubiquitin
Check for Full Text / PubMed Unique Identifier (PMID): 16397241
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.